PFIZER INCPFE

時価総額

$1423.6億

PER

研究開発型グローバルバイオ医薬品の最大手（1942年6月設立）。ワクチンや医薬品（Comirnaty、Paxlovid等）を展開。2022年にBiohavenを約118億ドルで買収、同年にArenaを約66億ドルで買収。約200カ国・地域に供給。

概要財務

サマリーテーブルに戻る

	2010年 12月31日	2011年 12月31日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Cash and cash equivalents	1,735	3,539	10,389	2,183	3,343	3,641	2,595	1,342	1,139	1,305	1,784	1,944	416	2,853	1,043
Short-term investments	-	-	-	-	-	-	-	-	-	-	10,437	29,125	22,316	9,837	19,434
Accounts Receivable, after Allowance for Credit Loss, Current	14,612	13,608	12,378	9,357	8,669	8,176	8,225	8,221	8,025	8,724	7,930	11,479	10,952	11,177	11,463
Inventories	8,405	7,769	7,063	6,166	5,663	7,513	6,783	7,578	7,508	8,283	8,046	9,059	8,981	10,189	10,851
Current tax assets	-	-	-	-	-	2,662	3,041	3,050	3,374	3,344	3,264	4,266	3,577	3,978	3,314
Other current assets	-	-	-	3,613	2,750	2,163	2,249	2,289	2,461	2,600	3,438	3,820	5,017	5,299	4,253
Total current assets	60,468	57,728	61,415	56,244	57,702	43,804	38,949	41,141	49,926	32,803	35,067	59,693	51,259	43,333	50,358
Equity-method investments	-	-	-	-	-	-	-	-	-	17,133	16,856	16,472	11,033	11,637	217
Long-term investments	-	-	-	-	-	-	-	-	-	-	3,406	5,054	4,036	3,731	2,010
Property, plant and equipment, net	19,123	16,938	14,461	12,397	11,762	13,766	13,318	13,865	13,385	13,967	13,900	14,882	16,274	18,940	18,393
Identifiable intangible assets, net	57,558	53,833	46,013	39,385	35,166	40,356	52,648	48,741	35,211	35,370	28,471	25,146	43,370	64,900	55,411
Goodwill	43,947	45,067	44,672	42,519	42,069	48,242	54,449	55,952	53,411	58,653	49,577	49,208	51,375	67,783	68,527
Deferred Tax Assets, Net, And Other Tax Assets, Noncurrent	-	-	-	-	1,544	1,794	1,812	1,855	1,924	2,099	2,383	3,341	6,693	3,706	8,662
Other noncurrent assets	-	-	-	3,596	3,513	3,499	3,323	3,227	2,799	4,450	4,569	7,679	13,163	12,471	9,817
Total assets	195,014	188,002	185,798	172,101	169,274	167,460	172,000	171,797	159,422	167,000	154,229	181,000	197,000	227,000	213,000
Debt, Current	5,623	4,018	6,424	6,027	5,141	10,160	10,688	9,953	8,831	16,195	2,703	2,241	2,945	10,350	6,946
Trade accounts payable	4,026	3,836	4,264	3,234	3,440	3,620	4,536	4,656	4,674	4,220	4,309	5,578	6,809	6,710	5,633
Dividends payable	-	1,796	1,734	1,663	1,711	1,852	1,944	2,029	2,047	2,104	2,162	2,249	2,303	2,372	2,437
Income taxes payable	946	1,013	1,010	678	531	418	437	477	1,265	980	1,049	1,266	1,587	2,349	2,910
Employee-related Liabilities, Current	2,108	2,169	2,046	1,792	1,784	2,359	2,487	2,196	2,397	2,720	3,058	3,332	3,407	2,776	3,838
Deferred revenues	-	-	-	-	-	-	-	-	-	-	-	3,067	2,520	2,700	1,511
Other current liabilities	-	-	-	9,951	9,024	10,990	11,023	11,115	10,753	11,083	12,640	24,939	22,568	20,537	19,720
Total current liabilities	28,609	28,069	28,619	23,366	21,631	29,399	31,115	30,427	31,858	37,304	25,920	42,671	42,138	47,794	42,995
Long-term debt	38,410	34,931	31,036	30,462	31,541	28,818	31,398	33,538	32,909	35,955	37,133	36,000	33,000	62,000	57,000
Liability, Defined Benefit Plan, Noncurrent	-	-	-	-	-	-	-	-	-	-	-	-	2,250	2,167	2,115
Noncurrent deferred tax liabilities	-	-	-	-	-	-	-	3,900	3,700	5,578	4,063	349	1,023	640	2,122
Other taxes payable	-	-	-	3,993	4,353	3,992	4,000	18,697	14,737	12,126	11,560	11,331	9,812	8,534	6,112
Other noncurrent liabilities	5,601	6,199	4,939	4,767	4,883	5,257	6,337	6,149	5,850	6,317	6,669	9,743	13,180	16,539	14,150
Total liabilities	106,749	105,381	104,120	95,481	97,652	102,463	111,776	100,141	95,664	104,042	90,756	104,013	101,288	137,213	124,899
Common Stock, Value, Issued	444	445	448	453	455	459	461	464	467	468	470	473	476	478	480
Additional paid-in capital	70,760	71,423	72,608	77,283	78,977	81,016	82,685	84,278	86,253	87,428	88,674	90,591	91,802	92,631	93,603
Treasury stock, shares at cost: 2024—3,926; 2023—3,916	-	-	-	-	-	-	-	-	-	-	-	-	-	-	114,763
Retained earnings	42,716	46,210	54,240	69,732	72,176	71,993	71,774	85,291	89,554	97,670	96,770	103,394	125,656	118,353	116,725
Accumulated other comprehensive loss	-3,440	-4,129	-5,953	-3,271	-7,316	-9,522	-11,036	-9,321	-11,275	-11,640	-11,688	-5,897	-8,304	-7,961	-7,842
Total Pfizer Inc. shareholders’ equity	88,265	82,621	81,678	76,620	71,622	64,998	59,840	71,656	63,758	63,447	63,473	77,462	95,916	89,288	88,497
Equity attributable to noncontrolling interests	452	431	418	313	321	278	296	348	351	303	235	262	256	274	294
Total equity	88,265	82,621	81,678	76,620	71,622	64,998	59,840	71,656	63,758	63,447	63,473	77,462	95,916	89,288	88,497
Total liabilities and equity	195,014	188,002	185,798	172,101	169,274	167,460	171,615	171,797	159,422	167,489	154,229	181,476	197,205	226,501	213,396